Chen Yang Luke Sells Shares of 111, Inc. (YI)

Insider Chen Yang Luke sold 3,400 shares of 111, Inc. on May 27, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 3:00 PM EDT

Key Points

Chen Yang Luke sold 3,400 shares of 111, Inc. valued at $850 on May 27, 2026.
Shares of 111, Inc. trade at $4.57 with a market cap of $40.2 million and a forward P/E of 32.64.
Recent insider transactions include sales by Sun Jian David and Chen Yang Luke in June 2026.

Chen Yang Luke, an insider at 111, Inc. (NasdaqGM: YI), recently sold 3,400 shares of the company. The transaction, which took place on May 27, 2026, was valued at approximately $850, with an average sale price of $0.25 per share.

Insider Buying and Selling at 111, Inc.

In addition to Chen Yang Luke's recent sale, other insiders have also been active. Sun Jian David sold 58,800 shares on June 15, 2026, at $0.23 per share, while Chen Yang Luke sold another 44,000 shares on the same day. Earlier, on June 12, 2026, Chen Yang Luke sold 49,920 shares at $0.23 per share. These transactions were not part of any pre-planned trading program.

Other Institutional Activity in 111, Inc.

Several institutional investors have adjusted their positions in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, ending with 13,014 shares valued at about $84,851. Serenus Wealth Advisors, LLC slightly reduced its stake by 64 shares, holding 4,320 shares worth approximately $321,334. Meanwhile, Citigroup Inc entered a new position with 207 shares valued at $1,341, and UBS Group AG reduced its holdings by 203 shares, now holding 100 shares worth $652.

111, Inc. Stock Snapshot

Shares of 111, Inc. are currently trading around $4.57. The company has a market capitalization of roughly $40.2 million and a forward P/E ratio of 32.64. It has a beta of 0.609, indicating lower volatility compared to the broader market. The stock's 52-week range spans from a low of $2.48 to a high of $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40.

Recent Earnings

111, Inc. reported revenue of approximately $11.39 billion, although it experienced a revenue decline of 33.1%. The company's net margin stands at -0.75%, with a return on equity of -14.84%. The next earnings report is expected on March 19, 2026.

About 111, Inc.

111, Inc., based in Shanghai, China, operates an integrated online and offline platform in the healthcare market. It serves pharmacies, pharmaceutical companies, and medical professionals, offering supply chain services, online pharmacy platforms, and a range of healthcare products. The company is led by CEO Mr. Junling Liu and employs over 1,000 people.

Bottom Line

Insider sales at 111, Inc., including those by Chen Yang Luke, offer a glimpse into the trading activities within the company. Investors often track such activity for potential insights, though it is important to note that these transactions do not necessarily indicate a lack of confidence. As always, 13F filings and insider activity reports are backward-looking and may not reflect current positions.